Halozyme Therapeutics, Inc.

NASDAQ:HALO

62.31 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Operating Activities:
Net Income 281.594202.129402.71129.085-72.24-80.3362.971-103.023-32.231-68.375-83.479-53.552-19.77-53.242-58.361-48.654-23.896-14.752-13.275-9.091-0.079-0.065-0.04
Depreciation & Amortization 84.85649.6412.9973.2844.0682.3882.1612.411.6771.7621.2271.0791.0961.5081.4441.0480.5760.2440.2060.123000
Deferred Income Tax 34.50640.005-155.4340.6440.49-3.085-0.2570.560.8871.691.1160.007000-3.6910000000
Stock Based Compensation 36.6224.39720.8217.20434.77635.69630.6725.58520.83815.2749.5388.3495.574.8664.5263.6960000000
Change In Working Capital -38.671-85.9513.738-108.366-50.539-5.86620.68816.978-29.4970.10622.103-20.221-21.2451.46812.248.53220.58920.299-0.1121.1520.0270.0070.003
Accounts Receivables -3.339-83.9416.755-38.288-29.43711.613-6.45316.73-23.261-0.0526.606-13.4410.0661.9163.021-6.4850000000
Inventory -26.884-17.4817.371-31.388-6.734-17.489.477-5.134-3.083-0.236-3.499-2.103-0.3740.966-0.7180.262-0.261-0.164-0.227-0.052000
Accounts Payables -12.54624.5351.167-41.2084.638-278.48715.629-0.24413.866-0.8167,888.535-3,263.487711.7773.437-24.7880000000
Other Working Capital 4.098-9.064-11.5552.518-19.006278.4882.0355.626-17.0191.21-7,869.5393,258.81-732.714-4.85111.9389.96620.8520.4630.1151.2040.0270.0070.003
Other Non Cash Items -10.3349.88924.60913.603-1.9781.69717.827.1071.2432.0250.1560.009-0.0020.0140.0033.6962.5831.2880.1850.0980.0020.0020.002
Operating Cash Flow 388.571240.11299.4455.454-85.423-49.5134.053-50.383-37.083-47.518-49.339-64.329-34.35-45.386-40.148-35.374-0.1487.08-12.996-7.718-0.05-0.056-0.034
Investing Activities:
Investments In Property Plant And Equipment -15.294-4.81-1.457-2.504-4.04-4.663-1.35-3.137-2.36-1.368-2.298-1.413-0.829-0.647-1.461-1.16-2.365-0.365-0.351-0.228000
Acquisitions Net 81.615-999.12404.8321.0761.509000000000000000000
Purchases Of Investments -292.911-255.208-652.515-226.185-389.759-311.112-398.187-155.412-71.482-88.884-48.947000000000000
Sales Maturities Of Investments 211.296746.127247.683305.967388.25318.268235.80581.78379.7357.3013.375000000000000
Other Investing Activites -81.61526.006-404.83280.858-1.5097.156-162.382-73.6298.248-31.583-45.572000000000000
Investing Cash Flow -96.909-487.005-406.28978.354-5.5492.493-163.732-76.7665.888-32.951-47.869-1.413-0.829-0.647-1.461-1.16-2.365-0.365-0.351-0.228000
Financing Activities:
Debt Repayment -13.483-447.453-369.064-19.56-108.082-77.516-15.995-54.2500-19.985000000000000
Common Stock Issued 7.87914.0512.53663.39314.22413.719134.8741.86513.098107.7135,079.04681.477059.96538.1742.5756.00318.34216.47215.5800.1270.061
Common Stock Repurchased -402.383-200.002-350.058-150.117-199.998000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 7.879995.776796.98763.393461.29513.71912.776203.00613.0986.788-5,053.98231.3414.7491.8587.1842.570007.87000
Financing Cash Flow -407.987362.37177.865-106.284153.215-63.797131.655150.62113.098114.50125.064112.8184.74961.82345.3582.5756.00318.34216.47223.4500.1270.061
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000
Net Change In Cash -116.325115.476-28.98427.52462.243-110.804101.97623.472-18.09734.032-72.14447.076-30.4315.7913.749-33.96353.4925.0573.12415.504-0.050.0710.026
Cash At End Of Period 118.37234.695119.219148.203120.67958.436169.2466.76443.29261.38927.35799.90152.82683.25667.46563.71697.67944.18919.13216.0080.0480.0970.026